Amador Bioscience provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
Amador Bioscience, a contract research organization (CRO) that provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 30, 2021 | Series B | $60M | 1 | — | — | Detail |
Sep 28, 2021 | Series B | — | 1 | Sequoia Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sequoia Capital | — | Series B |